Retatrutide 30mg
Select your preferred research format below. Both contain 30mg active compound for £180.00.
30mg Dose & Pen Dial Reference
Measurement reference for 30mg vials and quick pens — 10 units/clicks = 1mg.
Quick Pen Dial Guide
10 Units = 1mg| Dose | Pen Units | Doses / Pen |
|---|---|---|
| 1.0 mg | 10 Units | 30 doses |
| 2.0 mg | 20 Units | 15 doses |
| 4.0 mg | 40 Units | 7.5 doses |
| 6.0 mg | 60 Units | 5 doses |
Dial counts 0 1 2 3... Turn until window reads the exact unit number above.
Powder Vial — 3ml Bac Water
| Dose | Syringe Vol | 100U Syringe |
|---|---|---|
| 1.0 mg | 0.10 ml | 10 Ticks |
| 2.0 mg | 0.20 ml | 20 Ticks |
| 4.0 mg | 0.40 ml | 40 Ticks |
| 6.0 mg | 0.60 ml | 60 Ticks |
Based on 3.0ml Bacteriostatic Water added to 30mg lyophilised powder vial.
Product Details & Quality Verification
Retatrutide 30mg is an advanced triple-agonist research compound targeting GLP-1, GIP, and Glucagon receptors. Every PepMyTide batch undergoes third-party mass spectrometry protein analysis at Janoshik Analytical (Report #204678) to verify identity and purity exceeding 99%.
Quick Pen Protocol — 7 Steps
Pre-filled pens calibrated at 10 units = 1mg.
Room Temperature
Remove from fridge 10–15 mins before use. Cold solution dials less smoothly.
Inspect Cartridge
Hold to light. Solution must be clear, colourless with no floating particles.
Attach 31G Needle
Wipe septum with alcohol swab. Screw on a new 31G 6mm needle tightly.
Prime the Pen
Dial 2 units, point upward, press plunger until a small drop appears at tip.
Dial Your Units
Turn dial to your target (10 units = 1mg, 20 = 2mg, 40 = 4mg).
Dispense & Hold
Press plunger fully until dial reads 0. Hold 6–10 seconds before withdrawing.
Remove Needle & Refrigerate
Discard needle in sharps bin. Return pen to 2–8°C refrigeration away from light. Stable 4–6 weeks once unsealed.
Researcher Reviews
Verified purchaser feedback
"Exceptional purity verification — had it independently retested and the results matched exactly. Dispatch was next day, arrived cold and well packed. Will be ordering again."
"The Quick Pen is brilliant — so much easier than reconstituting. Dialling is precise and the COA link is genuinely useful for documentation. Highly recommend the pen format."
"Good quality, arrived fast and packaging is genuinely discreet. Docking one star only because I'd love a 10mg option for lower-dose protocols. Otherwise solid supplier."
"Ordered three times now. Consistent quality every batch — purity is always verified to spec. The WhatsApp ordering process is fast and they respond within minutes."
"Best UK source I've found for this compound. The dose guide on the site is genuinely helpful and I appreciate the real Janoshik COA — not just a logo slapped on a page."
"Super fast Royal Mail Tracked delivery, arrived cold with an ice pack. Pen dialling mechanism is solid — no leaks or issues after multiple uses. Professional outfit."
Frequently Asked Questions
PepMyTide supplies Retatrutide 30mg directly from our UK facility in plain vial or pre-filled Quick Pen format for £180.00 with fast cold-shipped delivery via Royal Mail Tracked 24.
The pen uses a standard unit system where 10 units = 1mg active compound. To select 1mg dial to 10 units; for 2mg dial to 20 units; for 4mg dial to 40 units.
Once reconstituted or unsealed, Retatrutide 30mg remains stable for approximately 4–6 weeks under continuous 2–8°C refrigeration away from direct light.
Yes. Every batch is tested by Janoshik Analytical — a fully independent third-party lab — via HPLC mass spectrometry. The published test report (#204678) is publicly verifiable at verify.janoshik.com and consistently shows purity exceeding 99%.
Order via WhatsApp for the fastest response — typically within minutes. Orders placed before 1 PM Monday–Friday are dispatched same day via Royal Mail Tracked 24, cold-packed for temperature stability in transit.
Get the Peptide Reconstitution Protocol Guide
Step-by-step reconstitution instructions, flash-sale discount codes, and instant COA notifications when fresh lab results land.
By subscribing you confirm you are 18+ and agree to receive research update emails. Unsubscribe anytime.